Ablation of EWS-FLI1 by USP9X inhibition suppresses cancer cell growth in Ewing sarcoma

被引：9

作者：

Wang, Shan ^{[1
,2
]}

Huo, Xiaofang ^{[2
]}

Yang, Yiping ^{[1
]}

Mo, Yingxi ^{[1
]}

Kollipara, Rahul K. ^{[2
]}

Kittler, Ralf ^{[2
,3
,4
,5
,6
]}

机构：

[1] Guangxi Med Univ, Dept Res, Canc Hosp, Nanning, Guangxi Zhuang, Peoples R China

[2] Univ Texas Southwestern Med Ctr, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX USA

[3] Univ Texas Southwestern Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX USA

[4] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX USA

[5] Univ Texas Southwestern Med Ctr Dallas, Green Ctr Reprod Biol Sci, Dallas, TX USA

[6] UT Southwestern Med Ctr, McDermott Ctr Human Growth & Dev, 5323 Harry Hines Blvd, Dallas, TX 75390 USA

来源：

CANCER LETTERS | 2023年 / 552卷

关键词：

Ewing sarcoma; USP9X; EWS-FLI1; Ubiquitination; WP1130; SHORT INTERFERING RNAS; EWS/FLI-1; PHENOTYPE; SURVIVAL; THERAPY; PROGRAM; FUSION;

D O I：

10.1016/j.canlet.2022.215984

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The neomorphic transcription factor EWS-FLI1 is a key driver of Ewing sarcoma. Ablation of EWS-FLI1 may present a promising therapeutic strategy for this malignancy. Here we found that the deubiquitinase, ubiquitin specific peptidase 9 X-linked (USP9X) stabilizes EWS-FLI1 protein expression in Ewing sarcoma. We show that USP9X binds the ETS domain of EWS-FLI1 in Ewing sarcoma cells and deubiquitinates EWS-FLI1 and that USP9X and EWS-FLI1 protein expression is correlated in clinical Ewing sarcoma specimens. We found that treatment of Ewing sarcoma cells with the USP9X inhibitor WP1130 mediates rapid EWS-FLI1 degradation in vitro and in vivo which coincides with reduced growth of Ewing sarcoma cells and tumors. Our results suggest that USP9X might be a potential therapeutic target to mediate EWS-FLI1 depletion in Ewing sarcoma.

引用

页数：8

共 50 条

[21] Suppression of FOXO1 is responsible for a growth regulatory repressive transcriptional sub-signature of EWS-FLI1 in Ewing sarcoma [J].

Niedan, S. ;

Kauer, M. ;

Aryee, D. N. T. ;

Kofler, R. ;

Schwentner, R. ;

Meier, A. ;

Poetschger, U. ;

Kontny, U. ;

Kovar, H. .

ONCOGENE, 2014, 33 (30) :3927-3938

[22] A phase I/II trial and pharmacokinetic study of mithramycin in children and adults with refractory Ewing sarcoma and EWS-FLI1 fusion transcript [J].

Grohar, Patrick J. ;

Glod, John ;

Peer, Cody J. ;

Sissung, Tristan M. ;

Arnaldez, Fernanda I. ;

Long, Lauren ;

Figg, William D. ;

Whitcomb, Patricia ;

Helman, Lee J. ;

Widemann, Brigitte C. .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (03) :645-652

[23] EWS-FLI1 and Activator Protein-1 (AP-1) Reciprocally Regulate Extracellular-Matrix Proteins in Ewing sarcoma Cells [J].

Croushore, Emma E. ;

Stipp, Christopher S. ;

Gordon, David J. .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (16)

[24] EWS-FLI1 Utilizes Divergent Chromatin Remodeling Mechanisms to Directly Activate or Repress Enhancer Elements in Ewing Sarcoma [J].

Riggi, Nicolo ;

Knoechel, Birgit ;

Gillespie, Shawn M. ;

Rheinbay, Esther ;

Boulay, Gaylor ;

Suva, Mario L. ;

Rossetti, Nikki E. ;

Boonseng, Wannaporn E. ;

Oksuz, Ozgur ;

Cook, Edward B. ;

Formey, Aurelie ;

Patel, Anoop ;

Gymrek, Melissa ;

Thapar, Vishal ;

Deshpande, Vikram ;

Ting, David T. ;

Hornicek, Francis J. ;

Nielsen, G. Petur ;

Stamenkovic, Ivan ;

Aryee, Martin J. ;

Bernstein, Bradley E. ;

Rivera, Miguel N. .

CANCER CELL, 2014, 26 (05) :668-681

[25] Therapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targeting [J].

Theisen, Emily R. ;

Pishas, Kathleen I. ;

Saund, Ranajeet S. ;

Lessnick, Stephen L. .

ONCOTARGET, 2016, 7 (14) :17616-17630

[26] Targeted inhibition of histone deacetylase leads to suppression of Ewing sarcoma tumor growth through an unappreciated EWS-FLI1/HDAC3/HSP90 signaling axis [J].

Ma, Yan ;

Baltezor, Michael ;

Rajewski, Lian ;

Crow, Jennifer ;

Samuel, Glenson ;

Staggs, Vincent S. ;

Chastain, Katherine M. ;

Toretsky, Jeffrey A. ;

Weir, Scott J. ;

Godwin, Andrew K. .

JOURNAL OF MOLECULAR MEDICINE-JMM, 2019, 97 (07) :957-972

[27] Targeted inhibition of histone deacetylase leads to suppression of Ewing sarcoma tumor growth through an unappreciated EWS-FLI1/HDAC3/HSP90 signaling axis [J].

Yan Ma ;

Michael Baltezor ;

Lian Rajewski ;

Jennifer Crow ;

Glenson Samuel ;

Vincent S. Staggs ;

Katherine M. Chastain ;

Jeffrey A. Toretsky ;

Scott J. Weir ;

Andrew K. Godwin .

Journal of Molecular Medicine, 2019, 97 :957-972

[28] EWS-FLI1 reprograms the metabolism of Ewing sarcoma cells via positive regulation of glutamine import and serine-glycine biosynthesis [J].

Sen, Nirmalya ;

Cross, Allison M. ;

Lorenzi, Philip L. ;

Khan, Javed ;

Gryder, Berkley E. ;

Kim, Suntae ;

Caplen, Natasha J. .

MOLECULAR CARCINOGENESIS, 2018, 57 (10) :1342-1357

[29] MicroRNA Content of Ewing Sarcoma Derived Extracellular Vesicles Leads to Biomarker Potential and Identification of a Previously Undocumented EWS-FLI1 Translocation [J].

Crow, Jennifer ;

Samuel, Glenson ;

Farrow, Emily ;

Gibson, Margaret ;

Johnston, Jefferey ;

Guest, Erin ;

Miller, Neil ;

Pei, Dong ;

Koestler, Devin ;

Pathak, Harsh ;

Liang, Xiaobo ;

Mangels, Cooper ;

Godwin, Andrew K. .

BIOMARKER INSIGHTS, 2022, 17

[30] Cell cycle arrest and apoptosis are early events in radiosensitization of EWS::FLI1+ Ewing sarcoma cells by Mithramycin A [J].

Lin, Mei Yun ;

Damron, Timothy A. ;

Horton, Jason A. .

INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2023, 99 (10) :1570-1583

← 1 2 3 4 5 →